BRIEF published on 06/08/2026 at 13:57, 3 months 9 days ago Virbac Reports Shares and Voting Rights for May 2026 Euronext Paris Voting Rights Shares VIRBAC May 2026
BRIEF published on 06/08/2026 at 13:57, 3 months 9 days ago Virbac: Declaration of Shares and Voting Rights as of May 2026 Euronext Paris Voting Rights Animal Health Financial Transparency Virbac Shares
PRESS RELEASE published on 06/08/2026 at 13:52, 3 months 9 days ago Virbac : Declaration of the number of shares and voting rights 05/2026 Declaration of the number of shares and voting rights for Virbac on Euronext Paris. Total voting rights: 12,706,758. Net voting rights: 12,697,722 Euronext Paris Voting Rights Shares Financial Market VIRBAC
BRIEF published on 05/07/2026 at 10:16, 4 months 10 days ago Virbac: Update of shares and voting rights Euronext Paris Voting Rights Actions Financial Regulation VIRBAC
BRIEF published on 05/07/2026 at 10:16, 4 months 10 days ago Virbac Reports Updated Shares and Voting Rights as of April 2026 Euronext Paris Voting Rights Financial Regulations April 2026 Virbac Shares
PRESS RELEASE published on 05/07/2026 at 10:11, 4 months 10 days ago Virbac : Declaration of the number of shares and voting rights 04/2026 Declaration of the number of shares and voting rights for VIRBAC on Euronext Paris. Total voting rights: 12,707,056. Total shares: 8,390,660 as of April 30, 2026 Euronext Paris Voting Rights Shares Financial Market VIRBAC
BRIEF published on 04/07/2026 at 11:10, 5 months 10 days ago Virbac: Declaration on voting rights as of March 31, 2026 Voting Rights Euronext Actions Finance VIRBAC
PRESS RELEASE published on 03/17/2026 at 19:00, 6 months ago Virbac: Public Release of the Year-End Consolidated Accounts at 31 December 2025
BRIEF published on 12/16/2025 at 09:58, 9 months 1 day ago Virbac Acquires Thyronorm to Combat Feline Hyperthyroidism Veterinary Medicine Animal Health Feline Hyperthyroidism VIRBAC Thyronorm
BRIEF published on 12/16/2025 at 09:58, 9 months 1 day ago Virbac acquires Thyronorm for the treatment of feline hyperthyroidism Acquisition Animal Health Feline Hyperthyroidism VIRBAC Thyronorm
Published on 09/17/2026 at 15:55, 5 hours 15 minutes ago Empress Announces Agreement to Acquire Tongon Gold Stream and Secures Debt Financing
Published on 09/17/2026 at 15:25, 5 hours 45 minutes ago AIAI Holdings' Constellation Network Launches Dôr Patient Journey with Proactive MD(R), Expanding Transformational AI In Healthcare
Published on 09/17/2026 at 15:00, 6 hours 10 minutes ago Norsemont Hits 41 Meters of 4.59 g/t Gold as Phase 3 Drilling Continues to Expand the Choquelimpie System
Published on 09/17/2026 at 15:00, 6 hours 10 minutes ago ECC Ventures 4 Announces Termination of Agreement With Cambria Gold Mines Inc.
Published on 09/17/2026 at 14:50, 6 hours 20 minutes ago Caldwell Strengthens Human Resources Practice with Addition of Ali Palmer as Partner
Published on 09/17/2026 at 19:00, 2 hours 10 minutes ago Max Verstappen Passes All 100 Karts in 14 Laps in Red Bull's Max vs 100
Published on 09/17/2026 at 18:58, 2 hours 11 minutes ago EQS-Adhoc: H2APEX Group SCA: General Partner of H2APEX Group SCA resolves to prepare for the transfer of its stock exchange listing from the Regulated Market (Prime Standard) to the Scale segment of the Frankfur
Published on 09/17/2026 at 18:25, 2 hours 45 minutes ago Magentic raises $18M to build the AI workforce for the physical world
Published on 09/17/2026 at 18:10, 3 hours ago A robust adjusted EBIT margin of 18.8%, driven by solid organic revenue growth of 7.4%
Published on 09/17/2026 at 17:46, 3 hours 24 minutes ago RBI categorically denies the allegations of short-seller report
Published on 09/17/2026 at 17:40, 3 hours 30 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 3 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 1 day 14 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
